Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

MagicMed Industries discloses new 5-HT2A receptor agonists

June 28, 2022

SAGE Therapeutics describes new GABA-A receptor modulators

June 27, 2022

Mindset Pharma collaborates with CAMH on preclinical evaluation of MSP-1014

June 23, 2022

Data in mice support potential of ATL-1102 for limb girdle muscular dystrophy R2

June 23, 2022

A novel Smad4-mutated mouse model of Myhre Syndrome

June 23, 2022

Katholieke Universiteit Leuven describes new TRPM3 antagonists

June 23, 2022

Lenire licenses VSN-16R from UCL for fragile X syndrome

June 20, 2022

Merck & Co. patents orexin OX2 receptor agonists

June 16, 2022

Vanderbilt University patents new muscarinic M4 receptor antagonists

June 15, 2022

Alpha Cognition announces discovery of GEM combinations ALPHA-0702 and ALPHA-0802

June 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...